Enflurane

   
Google
 
Web NewDrugInformation.com

Enflurane


Drug - Enflurane
The trade name of the product as shown on the labeling.

Dosage - LIQUID; INHALATION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Enflurane
Multiple ingredients are in alphabetical order.

Strength - 99.9%
The potency of the active ingredient(s), Enflurane. May repeat for multiple part products.

Applicant - MINRAD
The firm name holding legal responsibility for Enflurane. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 074396
The FDA assigned number to Enflurane. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Enflurane. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AN
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 29, 1994
The date Enflurane was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Enflurane. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Enflurane is in. Format is RX, OTC, DISCN.

Applicant Full Name - Minrad Inc
The full name of the firm holding legal responsibility for the new application of Enflurane.

Enflurane